Checklists, tools, help site manage QA/QI reviews

March 2010
Clinical Trials Administrator;Mar2010, Vol. 8 Issue 3, p30
The article offers information on basic tools that are needed for investigator-initiated clinical trials. The tools include using the MS Word worksheets, having a good clinical practice (GCP) checklists including adherence to protocol and safety monitoring and stressing on the importance of having a complete documentation of the research. Areas of focus for the GCP checklists include having the required curriculum vitae (CV) on the file, the completed financial disclosure forms and the protocol and the instruction manual.


Related Articles

  • Information about ongoing clinical trials for patients. Godlee, Fiona; Chalmers, Iain // BMJ: British Medical Journal (Overseas & Retired Doctors Edition;2/27/2010, Vol. 340 Issue 7744, p456 

    The article discusses the controversy over the demand from patients for information about ongoing trials. Among the reasons patients demand for such information are a wish to participate in research and access to treatments that are only available within the context of research. It is suggested...

  • No Plain English for UK Subjects. Laurence, Desmond // Applied Clinical Trials;Aug2006, Vol. 15 Issue 8, p94 

    The article comments on key controversies pertaining to the use of doublespeak in the patient recruitment process for clinical trials in Great Britain. Issues may arise if patients are not given sufficient information regarding the risks involved in clinical trials. The clinical trial sector in...

  • Evidence supporting platform-switching to preserve marginal bone levels not definitive. Stafford, Gary L // Evidence-Based Dentistry;Jun2012, Vol. 13 Issue 2, p56 

    Data sourcesMEDLINE, EMBASE, The Cochrane Oral Health Group's Trials Register, The Cochrane Central Register of Controlled Trials (CENTRAL), UK National Research Register, Australian New Zealand Clinical Trials Registry (ANZCTR), Database of Abstracts of Reviews of Effectiveness (DARE), ISI...

  • Let's Bring the Trial to the Subject! Hynes, Tim // Applied Clinical Trials;Jul2005, Vol. 14 Issue 7, p58 

    Focuses on the compliance and retention issues in a clinical trial. Assessment of the typical response to recruitment and retention problems; Visitation of the subject in the comfort and privacy of the home; Continuation of in-home visits performed by a qualified homecare agency; Consideration...

  • Fully informed consent is impossible in surgical clinical trials. Bernstein, Mark // Canadian Journal of Surgery;Aug2005, Vol. 48 Issue 4, p271 

    This article reports that fully informed consent by patient is impossible in surgical clinical trials. Consent for an investigative procedure has 3 distinct but interrelated elements that are essentially the same as for purely therapeutic procedures: disclosure, capacity and voluntariness. It is...

  • Statistics Notes: Concealing treatment allocation in randomised trials. Altman, Douglas G; Schulz, Kenneth F // BMJ: British Medical Journal (International Edition);8/25/2001, Vol. 323 Issue 7310, p446 

    Discusses the importance of concealing treatment allocation until a patient has entered a randomised clinical trial. Attempts to eliminate bias; How to ensure that allocation sequence will be concealed, including using external help; Difference between randomised and double blind trials.

  • Clinical trial regulation in Argentina: overview and analysis of regulatory framework, use of existing tools, and researchers' perspectives to identify potential barriers. White, Lauren; Ortiz, Zulma; Cuervo, Luis G.; Reveiz, Ludovic // Pan American Journal of Public Health;Nov2011, Vol. 30 Issue 5, p445 

    Objective. To review and analyze the regulatory framework of clinical trial registration, use of existing tools (publicly accessible national/international registration databases), and users' perspectives to identify possible barriers to registration compliance by sponsors and researchers in...

  • Involving consumers in designing, conducting, and interpreting randomised controlled trials: questionnaire survey. Hanley, Bec; Truesdale, Ann; King, Andy; Elbourne, Diana; Chalmers, Iain // BMJ: British Medical Journal (International Edition);03/03/2001, Vol. 322 Issue 7285, p519 

    Conclusions: Consumer involvement in the design and conduct of controlled trials seems to be growing and seems to be welcomed by most researchers. Such involvement seems likely to improve the relevance to consumers of the questions addressed and the results obtained in controlled trials.

  • Societal responsibilities of clinical trial sponsors. Evans, Stephen; Pocock, Stuart // BMJ: British Medical Journal (International Edition);03/10/2001, Vol. 322 Issue 7286, p569 

    Editorial. Discusses the societal responsibilities of clinical trial sponsors. Suggestion that lack of commercial pay off is not a legitimate reason for stopping trials; How a large long term randomized trial is a substantial commitment by the sponsor, principal scientific investigators and...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics